$MWAI MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000.
https://www.otcmarkets.com/stock/MWAI/news/Me...?id=511344
Clearwater, FL, February 23, 2026 / PRNewswire/ - MedWell Ai, Inc, (OTCQB: MWAI) (“Company”) is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025.
The Company reported $548,315 in Revenue for its fiscal second quarter of 2025. This performance was result of a successful strategic shift toward building an AI-driven healthcare, pharmaceutical and biological wellness portfolio.
Key Financial Highlights:
Increased Total Revenues:
· For three months, ended December 31, 2025, Company had generated total revenues of 548,315 vs $142,861 for three months, ended December 31, 2024 (280%+ increase).
· For six months, ended December 31, 2025, Company had generated total revenues of $1,075,806 vs $144,009 for six months, ended December, 2024 (700%+ increase).
Reduced Total Loss From Operations:
For three months, ended December 31, 2025, Company’s net loss was reduced to $266,221 vs $315,096 for three months, ended December 31, 2024.
For six months, ended December 31, 2025, Company’s net loss was reduced to $592,255 vs $904,080 for six months, ended December 31, 2024.
Reduced General And Administrative Expenses:
For three months, ended December 31, 2025, Company’s expenses were reduced to $388,509 vs $625,199 for three months, ended December 31, 2024.
For six months, ended December 31, 2025, Company’s expenses were reduced to $796,839 vs $960,413 for six months, ended December 31, 2024.
Reduced Net Loss Per Common Share:
For three months, ended December 31, 2025, Company’s net loss was reduced to 0.045 cents vs 0.062 cents for three months, ended December 31, 2024.
For six months, ended December 31, 2025, Company’s net loss was reduced to 0.138 cents vs 0.174 cents for six months, ended December 31, 2024.
Total Liabilities/Mezzanine/Stockholder’s Deficit: For three months, ended December 31, 2025, Company’s liabilities deficit was reduced to $468,655 from $805,500, for three months, ended June 30, 2025.
https://www.otcmarkets.com/stock/MWAI/news/Me...?id=511344
Clearwater, FL, February 23, 2026 / PRNewswire/ - MedWell Ai, Inc, (OTCQB: MWAI) (“Company”) is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025.
The Company reported $548,315 in Revenue for its fiscal second quarter of 2025. This performance was result of a successful strategic shift toward building an AI-driven healthcare, pharmaceutical and biological wellness portfolio.
Key Financial Highlights:
Increased Total Revenues:
· For three months, ended December 31, 2025, Company had generated total revenues of 548,315 vs $142,861 for three months, ended December 31, 2024 (280%+ increase).
· For six months, ended December 31, 2025, Company had generated total revenues of $1,075,806 vs $144,009 for six months, ended December, 2024 (700%+ increase).
Reduced Total Loss From Operations:
For three months, ended December 31, 2025, Company’s net loss was reduced to $266,221 vs $315,096 for three months, ended December 31, 2024.
For six months, ended December 31, 2025, Company’s net loss was reduced to $592,255 vs $904,080 for six months, ended December 31, 2024.
Reduced General And Administrative Expenses:
For three months, ended December 31, 2025, Company’s expenses were reduced to $388,509 vs $625,199 for three months, ended December 31, 2024.
For six months, ended December 31, 2025, Company’s expenses were reduced to $796,839 vs $960,413 for six months, ended December 31, 2024.
Reduced Net Loss Per Common Share:
For three months, ended December 31, 2025, Company’s net loss was reduced to 0.045 cents vs 0.062 cents for three months, ended December 31, 2024.
For six months, ended December 31, 2025, Company’s net loss was reduced to 0.138 cents vs 0.174 cents for six months, ended December 31, 2024.
Total Liabilities/Mezzanine/Stockholder’s Deficit: For three months, ended December 31, 2025, Company’s liabilities deficit was reduced to $468,655 from $805,500, for three months, ended June 30, 2025.
